MRNA Moderna Inc
Company Analysis
Latest News
🟢 MRNA extends move to 6.7% up
MRNA is trading at $63.30, up 6.7% versus the comparison close of $59.34 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA is trading 4.8% up today, rebounding on continued FDA flu vaccine panel optimism
MRNA is trading 4.8% up at $62.17 as it rebounds from yesterday's sharp sell-off on continued optimism surrounding its flu vaccine pipeline. • The stock is...
🟢 Moderna Inc is trading 4.6% up today as FDA panel reviews flu vaccine and positive briefing documents emerge
• Moderna Inc. is trading 4.6% up today at $64.67, extending a powerful multi-day rally driven by recent company-specific developments. • The FDA's Vaccines...
🟢 Moderna Inc makes sharp 10.1% jump
MRNA is trading at $61.02, up 10.1% versus the comparison close of $55.40 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc extends move to 5.1% up
MRNA is trading at $58.22, up 5.1% versus the comparison close of $55.40 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc is trading 4.15% up today on new operating model, 2027-2028 product launch outlook, and favorable FDA flu vaccine data
Moderna Inc is trading 4.15% up now at $57.70, extending a sharp multi-day rally as investors react to the company’s new operating model, leadership...
Moderna Restructures Leadership for Future Product Launches
Moderna changed its operating model. The company prepares for multiple product launches. These launches are anticipated in 2027 and 2028. President Dr....
Moderna flu shot clears FDA review, despite gaps in clinical data
FDA staff found no major deficiencies in Moderna’s experimental mRNA flu vaccine, mFlusiva (mRNA-1010). Briefing documents released ahead of a June 18...
🟢 Moderna Inc makes sharp 10.1% jump
MRNA is trading at $57.37, up 10.1% versus the comparison close of $52.13 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc is trading 5.9% up today as flu vaccine study shows superior immunity
Moderna Inc is trading 5.9% up now at $55.22 after a study published in Nature Immunology showed its investigational flu vaccine, mRNA-1010, generated broader...
Moderna Flu Vaccine Triggers Broader Immunity, Nature Study Shows
Moderna’s investigational mRNA-1010 vaccine generates a broader and more durable immune response than standard flu shots, according to a study published in...
🟢 Moderna Inc is trading 4% up today amid broad market surge and risk-on sentiment
Moderna Inc is trading 4% up at $51.91 as investors rotate into risk assets during a broad market surge. • The stock is outperforming recent levels despite a...
🟢 Moderna Inc extends move to 5.4% up
MRNA is trading at $48.49, up 5.4% versus the comparison close of $45.99 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc is trading 4.1% up today as growth and biotech stocks rebound
Moderna Inc is trading 4.1% up at $47.89 today, recovering part of yesterday’s pullback and recent volatility as broader markets trend higher. • The move...
🔴 Moderna Inc is trading 4% down today amid a broader tech pullback and rate concerns
Moderna Inc is trading 4% down today at $45.81, sliding alongside a broader pullback in tech and growth stocks as investors react to higher-for-longer rate...
🔴 Moderna Inc is trading 4.1% down today on broad tech weakness and rate fears despite positive trial news
Moderna Inc is trading 4.1% down today at $45.64, underperforming as tech and growth stocks slide amid renewed higher-for-longer interest rate fears. • The...
Moderna and Oxford University Get UK Approval for Cancer Prevention Vaccine Trial
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) authorized Moderna and the University of Oxford to begin a Phase 1/2 clinical trial. This...
🔴 Moderna Inc is trading 5.7% down today on profit-taking after a cancer vaccine-driven rally
Moderna Inc is trading 5.7% down at $48.65 as the stock consolidates gains following a sharp two-day rally. • The recent surge was driven by upbeat cancer...
🔴 Moderna Inc is trading 4.3% down today as it consolidates gains after a cancer vaccine-driven rally
Moderna Inc is trading 4.3% down at $49.37 as the stock consolidates gains following a significant multi-day surge driven by positive clinical data. • The...
🟢 Moderna Inc is trading 5% up today as investors cheer positive 5-year cancer vaccine data
Moderna Inc is trading 5% up at $51.61, continuing a multi-day rally after the company presented highly positive long-term data for its personalized cancer...